Pfizer buys a portion of a vaccine plant from Baxter, J&J sells a vax facility to PaxVax

Pfizer ($PFE) is picking up a "portion" of a Baxter International ($BAX) vaccine manufacturing facility in Orth, Austria, as part of a $635 million deal to buy that company's marketed vaccine portfolio. Separately, Johnson & Johnson sold a vax facility near Bern, Switzerland, to PaxVax as part of a deal for the California-based company to acquire J&J's oral typhoid vaccine, Vivotif, for an undisclosed amount. Story | Story